324.50

2.07% 6.54

Medpace Holdings Inc (MEDP)

Overview News Price History Option Chain Financials Discussions Forecast

Medpace Holdings Inc stock is traded at $324.50, with a volume of 164.34K. It is up +2.07% in the last 24 hours and down -5.39% over the past month. Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical-device firms. It also offers ancillary services such as bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has over 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati and its operations are principally based in the us, but it also operates in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.

Previous Close:

$317.96

Open:

$316.2

24h Volume:

164.34K

Relative Volume:

0.50

Market Cap:

$9.97B

Revenue:

$2.03B

Net Income/Loss:

$339.79M

P/E Ratio:

38.00

EPS:

8.54

Net Cash Flow:

$502.80M

1W Performance:

-1.58%

1M Performance:

-5.39%

6M Performance:

-17.33%

1Y Performance:

+18.36%

1-Day Range:

$315.39

$324.92

1-Week Range:

$310.92

$331.99

52-Week Range:

$268.16

$459.77

Medpace Holdings Inc Stock (MEDP) Company Profile

Name

Medpace Holdings Inc

Sector

Healthcare (1181)

Industry

Diagnostics & Research (57)

Phone

(513) 579-9911

Address

5375 MEDPACE WAY, CINCINNATI, OH

Employee

5,900

Twitter

@WorkatMedpace

Next Earnings Date

2024-10-21

Latest SEC Filings

MEDP's Discussions on Twitter

Medpace Holdings Inc Stock (MEDP) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Oct-14-24	Initiated	Redburn Atlantic	Buy
Sep-27-24	Downgrade	UBS	Buy → Neutral
Sep-25-24	Downgrade	Jefferies	Buy → Hold
Aug-01-24	Initiated	Truist	Hold
May-29-24	Initiated	TD Cowen	Buy
May-28-24	Initiated	Mizuho	Buy
Apr-23-24	Upgrade	Jefferies	Hold → Buy
Mar-18-24	Initiated	Deutsche Bank	Hold
Feb-15-24	Upgrade	UBS	Neutral → Buy
Oct-24-23	Upgrade	Robert W. Baird	Neutral → Outperform
May-08-23	Upgrade	Guggenheim	Neutral → Buy
Oct-27-22	Upgrade	UBS	Sell → Neutral
Sep-07-22	Initiated	UBS	Sell
May-24-22	Initiated	Guggenheim	Neutral
Aug-05-21	Resumed	Credit Suisse	Outperform
Oct-02-20	Upgrade	Truist	Hold → Buy
Jun-08-20	Upgrade	Robert W. Baird	Underperform → Neutral
May-13-20	Downgrade	Wolfe Research	Outperform → Peer Perform
Apr-30-20	Upgrade	SunTrust	Sell → Hold
Apr-20-20	Downgrade	Robert W. Baird	Neutral → Underperform
Mar-17-20	Downgrade	SunTrust	Hold → Sell
Jan-27-20	Downgrade	SunTrust	Buy → Hold
Oct-31-18	Upgrade	SunTrust	Hold → Buy
Sep-17-18	Initiated	SunTrust	Hold
Jul-31-18	Upgrade	William Blair	Mkt Perform → Outperform
Nov-01-17	Downgrade	William Blair	Outperform → Mkt Perform
Sep-29-17	Initiated	Raymond James	Mkt Perform
Jul-10-17	Downgrade	KeyBanc Capital Mkts	Overweight → Sector Weight

View All

Medpace Holdings Inc Stock (MEDP) Latest News

02:49 AM

MEDP Investors Have Opportunity to Join Medpace Holdings, Inc. F - GuruFocus.com

02:49 AM

Nov 04, 2024

MEDP Investigation Notice: Kessler Topaz Meltzer & Check, LLP En - GuruFocus.com

Nov 04, 2024

MEDP INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC - GlobeNewswire

Nov 04, 2024

What Makes Medpace Holdings (MEDP) a Good Holding? - Insider Monkey

Nov 04, 2024

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Medpace Holdings, Inc. (MEDP) and Encourages Investors to Learn More About the Investigation - AccessWire

Nov 04, 2024

Nov 02, 2024

Medpace Holdings, Inc. (NASDAQ:MEDP) Stake Lowered by Integrated Advisors Network LLC - MarketBeat

Nov 02, 2024

Nov 01, 2024

Wolf Haldenstein Adler Freeman & Herz LLP announces that it - GlobeNewswire

Nov 01, 2024

Wolf Haldenstein Adler Freeman & Herz LLP announces that it is investigating Medpace Holdings, Inc. for potential violations of securities laws - GlobeNewswire Inc.

Nov 01, 2024

Medpace: A Compelling Long-Term Opportunity Amid Short-Term Headwinds (NASDAQ:MEDP) - Seeking Alpha

Nov 01, 2024

Stephens Investment Management Group LLC Acquires 3,889 Shares of Medpace Holdings, Inc. (NASDAQ:MEDP) - MarketBeat

Nov 01, 2024

Oct 31, 2024

Medpace cut to neutral by Baird, slowed revenue growth cited - MSN

Oct 31, 2024

abrdn plc Reduces Position in Medpace Holdings, Inc. (NASDAQ:MEDP) - MarketBeat

Oct 31, 2024

Oct 30, 2024

Wolf Haldenstein Adler Freeman & Herz LLP announces that it is investigating Medpace Holdings, Inc. for potential violations of securities laws - AccessWire

Oct 30, 2024

MEDP Investigation Notice: Kessler Topaz Meltzer & Check, LLP Encourages Medpace Holdings, Inc. (NASDAQ: MEDP) Investors with Significant Losses to Contact the Firm - PR Newswire

Oct 30, 2024

International Assets Investment Management LLC Buys 57,265 Shares of Medpace Holdings, Inc. (NASDAQ:MEDP) - MarketBeat

Oct 30, 2024

Oct 29, 2024

Bragar Eagel & Squire, P.C. Is Investigating Aviat, - GlobeNewswire

Oct 29, 2024